BioNTech obtained the candidate when it bought Biotheus last month in an acquisition deal that could reach up to $950 million. BioNTech on Tuesday revealed Phase Ib/II data for its investigational ...

Moreover, extensive drug screening and development have enabled some secretase inhibitors and modulators to advance into late-Phase clinical trials. This review focuses on recent progresses in ß ...

Source: Shutterstock Researchers compared the nephrotoxicity of VEGF tyrosine kinase inhibitor (TKI) therapy alone, the combination of a VEGF TKI and an immune checkpoint inhibitor (ICI), and ICI ...

This review discusses the vasculature-immunity crosstalk in the tumor microenvironment and summarizes the latest advances in combining anti-angiogenic therapy and immune checkpoint inhibitors to treat ...

Low-Impact Development (LID) By managing water runoff at its source through techniques like bioswales and retention ponds, low-impact development reduces flooding risks while protecting water quality.

China's latest push to promote the reform and innovative development of digital trade is expected to foster new growth drivers for foreign trade, inject fresh impetus into high-quality economic ...

The role for other anti-VEGF and EGF receptor inhibitors continues to be investigated. Not only new therapeutic agents, but also the identification of patients that would benefit the most from ...

We sought to address this issue by conducting a systematic review and meta-analysis of studies investigating one such biomarker, vascular endothelial growth factor (VEGF), in SSc patients and healthy ...

The Wistar Institute's Alessandro Gardini, Ph.D., and lab have shed new light on how certain biological processes determine the development of neural cells. Their findings on a molecular "bridge ...